Peter Kelling
Strong trading year prompts Diaceutics to accelerate investment plans
BELFAST-based diagnostics technology firm Diaceutics has reported a strong trading performance over the last calendar trading year and says it plans to "accelerate and enhance the company’s investment" in its operations over the next two years.
Sales grow in first half of year as contract values soar at Diaceutics
BELFAST data analytics and diagnostic commercialisation company Diaceutics has reported a 25 per cent growth in revenues in the first half of this year while its order book has almost tripled.
Diaceutics signs 10-year lease on Kings Hall medical hub
LONDON-listed diagnostic commercialisation company Diaceutics has confirmed plans to move its head office to the new Dataworks precision medicine hub at Kings Hall Life Sciences Park in Belfast.
Data firm Diaceutics sees revenues lift to £13.4m in first full year of AIM trading
DATA analytics firm Diaceutics, which last year became the fourth Northern Irish company to list on the London Stock Exchange, has revealed that its revenues at the end of its first full year of trading have risen by nearly a third from £10.